课题基金 / 基金详情

PHENOTYPE AND ETIOLOGY OF PALLISTER/HALL SYNDROME

PHENOTYPE AND ETIOLOGY OF PALLISTER/HALL SYNDROME
帕利斯特/霍尔综合征的表型和病因
批准号:
6108953
负责人:
LESLIE G BIESECKER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

LESLIE G BIESECKER的其他基金

相似基金

相关文献

中文摘要
翻译
该项目面向临床和 Pallister-Hall综合征患者的分子特征 以及相关的疾病。在这个方案中,我们执行临床 特征包括放射学和磁学成像,临床 检查,面谈,行为和精神评估, 呼吸道成像和其他研究。我们的目标是记录 小灵通的自然历史和表现范围。此外,我们 正在招募患有与小灵通相关的障碍的患者, 要么是因为已知它们是等位基因,要么是因为它们具有表型 重叠。分子特征试图定义的范围 导致小灵通及相关疾病的突变。具体地说,是如何 这些突变与特定的表型效应和细胞有关 正常和突变的GLI3的生物学效应。
英文摘要
The project is oriented towards the clinical and molecular characterization of patients with Pallister-Hall syndrome and related disorders. In this protocol we perform clinical characterization including radiologic and magnetic imaging, clinical examination, interviews, behavioral and psychiatric evaluation, airway imaging, and other studies. The goal is to document the natural history and range of expressivity of PHS. In addition, we are recruiting patients who have disorders that are related to PHS, either because they are known to be allelic or they have phenotypic overlap. The molecular characterization seeks to define the range of mutations that cause PHS and related disorders. Specifically, how those mutations relate to specific phenotypic effects and to the cell biologic effects of normal and mutant GLI3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HEMATOPOIETIC GROWTH FACTORS IN THE EARLY EMBRYO
HEMATOPOIETIC GROWTH FACTORS IN THE EARLY EMBRYO
HEMATOPOIETIC GROWTH FACTORS IN THE EARLY EMBRYO
GENE DOSAGE IN THE ETIOLOGY OF MULTIPLE CONGENITAL ANOMALIES
海外基金